Wed, May 10, 2023

Oren Livnat Reiterated (XERS) at Strong Buy and Held Target at $6 on, May 10th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-6-on-may-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Oren Livnat of HC Wainwright & Co., Reiterated "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy and Held Target at $6 on, May 10th, 2023.

Oren has made no other calls on XERS in the last 4 months.



There is 1 other peer that has a rating on XERS. Out of the 1 peers that are also analyzing XERS, 0 agree with Oren's Rating of Hold.



This is the rating of the analyst that currently disagrees with Oren


  • Roanna Ruiz of "SVB Leerink" Maintained at Buy with Decreased Target to $5 on, Friday, January 27th, 2023

Publication Contributing Sources